Table of Contents
Advances in Andrology
Volume 2014 (2014), Article ID 207901, 6 pages
Review Article

A Personal Reflection of Greenlight 532 nm Laser for BPH Treatment

Department of Urology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, 425 East 61st Street, New York, NY 10065, USA

Received 11 March 2014; Revised 23 August 2014; Accepted 26 August 2014; Published 18 September 2014

Academic Editor: Enzo Vicari

Copyright © 2014 Bilal Chughtai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia are a bothersome symptom set that affect approximately one in every four males above the age of 50. First line treatment is typically medication, but when medications fail surgical therapy is the next option. Technological advances have made surgical therapy safer and more effective. One area that our group has particular interest and focus in is the application of the 532 nm laser in surgical therapy. The high power 532 nm laser is used to remove obstructive prostatic tissue and the laser energy is selectively absorbed by hemoglobin in the prostate tissue, resulting in effective tissue vaporization and removal. We review our experience with Greenlight laser system and its evolution from the original 60-watt laser to the most recent 180-watt Greenlight system with MoXy fiber.